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Does propranolol reduce blood pressure only by blocking presynaptic
beta-adrenoceptors? J. Burns, B. Waeber, and H. R. Brunner. Division
of Nephrology and Hypertension, Centre Hospitalier Universitaire,
Lausanne, Switzerland. Propranolol (P) might reduce blood pressure
(BP) by blocking presynaptic beta-adrenoceptors. Epinephrine absence
should then reduce or abolish the antihypertensive effect of P. Biadren-
alectomized Wistar-Kyoto rats (AX) were made hypertensive with
methylprednisolone (20 mg/kg s.c. once/week x 2 week) supplemented
with deoxycorticosterone pivalate (10 mg/kg weekly). Sham-operated
control rats (Sham) received the same treatment. Baseline weight, mean
intra-arterial BP, and heart rate (HR) of the groups were the same. After
P (5 mg/kg) was administered subcutaneously to unanesthetized rats,
BPfell from (mean SD) 151 14 by 24 12mm Hg in AX(N = II)
within 90 mm and from 153 13 by only 7 tO mm Hg in Sham (N =
II, P < 0.001); HR fell 91 44 beats/mm in AX and 40 36 beats/mm
in Sham (P < 0.01). Propranolol's vehicle had no effect. At the end of
the experiment, plasma epinephrine levels of AX were less than 40
pg/mi; those of Sham were 420 210 pg/mI. Norepinephrmne levels were
similar. Since BP fell despite virtual absence of circulating epinephrine,
these results indicate P reduces BP at least in part by other mechanisms
than presynaptic beta-adrenoceptor blockade. The simultaneous de-
crease in BP and HR in the absence of circulating epinephrine is
compatible with propranolol-induced reduction of sympathetic nerve
activity.
Stereoselective metabolism of bufuralol. P. Dayer, A. Kdpfer, R.
Francis, and J. Fabre. Hdpital Cantonal Universitaire, Geneva, Swit-
zerland. Most /3-adrenoceptor blocking drugs are administered as
racemic mixture of (+) and (—) isomers but their pharmacological
activity is confined to the (—) isomer. The genetic oxidation polymor-
phism ("debrisoquine type") is a major source of variability in f3-
blocking drug kinetics. Using bufuralol as the test compound, we
investigated the influence of the genetic status on stereoselectivity in /3-
blocking drug oxidation. Four healthy volunteers selected as extensive(EM) and poor (PM) metabolizers for debrisoquine and bufuralol
received, when fasting, 2.5 mg of (+/—), (+) and (—) bufuralol orally.
Urine samples were collected for 8 hr. Samples were assayed for
bufuralol, I 'OH-bufuralol (or carbinol, the main plasma metabolite) and
their conjugated derivatives using a I-IPLC method. Most of the (+)
bufuralol is excreted as glucuro-conjugated derivative (>90%). the (—)
isomer seems to be less extensively conjugated. The (+) to (—) ratio of
bufuralol urinary excretion is 6.9 (EM) and 2.6 (PM). The carbinol is
excreted mainly unconjugated (>90%). Oxidation of bufuralol was
assessed by measuring the carbinol urinary excretion. The mean
carbinol excretion (g/8 hr) was:
(+/—) (+) (—) (+)/(-) ratio
EM (2) 164 274 105 2.6
PM (2) 63 72 52 1.4
The carbinol comes mainly from the (+) isomer. The stereoselectivity
in metabolism tends to disappear in PM. As expected, there is a
clear decrease in carbinol production in PM. /3-adrenoceptor blocking
drug elimination is stereoselective. This fact may be relevant when
considering concentration/effect relationship after racemic mixture
administration.
Interindividual variability in fJ-adrenoceptor blocking drug behavior: a
comparison of atenolol, bopindolol, and metoprolol. P. Dayer, A.
Marmy, T. Leemann, J. Rosentlia/er and J. Fabre. HOpital Cantonal
Universitaire, Geneva, Switzerland. Hepatic oxidation under genetic
control is one of the major sources of variation in /3-blocking drug
plasma concentrations. The aim of this study was to compare the
influence of the oxidation phenotype on the behavior of a nonmetabo-
lized drug, atenolol, and two oxidized drugs, bopindolol and metopro-
lol, in order to assess their interindividual variability. Ten healthy
volunteers—six extensive (EM) and four poor (PM) metabolizers for
debrisoquine and bufuralol—received, when fasting, 50 mg atenolol, I
mg bopindolol and 100 mg metoprolol orally, according to a double
blind randomized design. Blood samples were collected and cardiac
effect recorded (% inhibition of exercise-induced tachycardia, 200
watts/3') at 0, 3, 9 and 24 hr after the drug administration. Plasma
concentrations were measured using a GC assay (atenolol), a radio-
receptor assay (bopindolol active derivatives) and a HPLC assay
(metoprolol). The oxidation polymorphism does not influence atenolol
disposition. There is a slight, but significant, difference in bopindolol
plasma concentrations between EM and PM. However, this difference
is not significant in term of cardiac effects. In contrast, the oxidation
polymorphism has a major influence on metoprolol plasma concentra-
tions and effects. The time course of cardiac blockade is (th SD):
3hr 9hr 24 hr
Atenolol 50mg 20.6 5.1 14.5 6.7 8.4 6.0
Bopindolol 1 mg 29.3 5.5 24.3 5.4 14.1 5.4
Metoprolol 100 mg 22.0 9.0 13.4 8.7 6.7 4.5
One mg bopindolol has more pronounced effects and a longer duration
of action than 50 mg atenolol and 100 mg metoprolol (rank sum test
significant at all times). Despite the genetic dependency of its metabo-
lism, bopindolol has a stable and predictable effect.
Sicca syndrome and glomerulopathy. D. Dupont, F. Chatelanat, and
H. Favre. Division of Nephrology, Department of Medicine and
Department of Pathology, Hôpital Cantonal (Iniversitaire de Genêve,
Geneva, Switzerland. A 61-year-old patient was admitted to the hospital
for accelerated hypertension, nephrotic syndrome associated with renal
failure (Ccr; 25 mI/mm), and Sicca syndrome. The whole symptomatol-
ogy started 2 months before admission following an IVP. Clinical
examination revealed + + + edema, elevated BP (250/130 mm Hg) and
stage 3 hypertensive retinopathy. The remaining status was irrelevant.
Laboratory data included: CH50, 21%; latex; lupus serology; cryoglobu-
lins, negative; salivary ducts autoantibodies, positive. Renal biopsy
specimens showed massive and homogeneous intracapillary deposits
with macrophagic reactions and mesangial proliferation at light micros-
copy. These deposits exhibited a fibrillar structure and a subendothelial
location at electron microscopy. They had no characteristics for
amyloid structure and did not fix IgG, 1gM, IgA, or complement
antisera at immunohistological study. In conclusion, this observation
points out a peculiar aspect of glomerulopathy associated with Sicca
syndrome, characterized by massive intracapillary glomerular deposits.
Cyclosporin A (CyA) and hyperlipidemia after renal transplantation.
K. Hodel, R.-C. Mordasini, F. Brunner, J. Landniann, and G. Thiel.
Departments of Internal Medicine and Surgery, University of Basel,
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Base!, Switzerland. Hyperlipidemia is common after renal transplanta-
tion and has been attributed, at least in part, to corticosteroid therapy.
We, therefore, studied serum lipids in a group of nondiabetic transplant
recipients on CyA montherapy (CyA 9.4 2.9 mg/kg/day) in compari-
son to a simultaneously transplanted group on conventional immuno-
suppression with azathioprine and prednisone (Aza/P). Mean SD
fasting serum lipid levels at 5 to 16 months (CyA) and at 7 to 25 months
(Aza/P) after transplantation are given below.
Azathioprine
prednisone
CyA-
Monotherapy Normal range
N=9 N=ll
Triglycerides 209 92 252 76 50 to 200 mg%
Triglycerides >200 4/9 8/I I
Total cholesterol 281 74 270 31 ISO to 250 mg%
Cholesterol >250 5/9 6/Il
LDL-Cholesterol 183 63 155 48 <200 mg%
VLDL-Cholesterol 40 26 54 31
Apoprotein B 124 45 121 25 60 to 100 mg%
Mean age at transp 46 9 49 13
Serum creatinine,
moles/liter 130 61 200 84
Body weight, kg 62 13 69 IS
In conclusion, atherogenic hypercholesterolemia (Frederickson types
2a and b) was found as frequently in patients on CyA as in those on
Aza/P. It does not appear unlikely, therefore, that the role of corticoste-
roids in raising serum lipid levels of renal transplant recipients has been
overestimated.
Compensatory adaptation of renal functions in the adrenalectomized,
glucocorticoid-substituted rat. J. D. Horisberger andf. Diezi. Inst it ut de
Pharmacologie de I'Unh'ersité, Lausanne, Switzerland. It has been
shown previously that the early compensatory natriuresis following
unilateral nephrectomy (UNX) was abolished in adrenalectomized
animals but could be re-established by large doses of prednisolone. The
present studies aimed at investigating the role of glucocorticoids in this
compensatory adaptation. Twenty-four-hour adrenalectomized rats re-
ceived dexamethasone (5 pg/kg) as glucocorticoid substitution. One
kidney was excluded, and the functional changes of the remaining
kidney (GFR, urine flow, Na, and K excretion) were monitored at 15-
mm intervals during the following 2 hr. The acute intravenous Na load
was adjusted to obtain identical Na balance in UNX (N = 12) and
control, sham-operated (N = 10) rats. Identical Na balance was reached
when UNX rats received 75% of control Na load. Within 15 to 30 mm
after UNX, FENa started to increase significantly as compared to
control rats; K excretion increased from the first 15 mm and onwards.
GFR per kidney did not show consistent changes during the experi-
ment. Urine flow decreased significantly during the first 15 mm, but
increased significantly thereafter. Similar results were obtained in a
separate group of animals not submitted to adrenalectomy. These
studies indicate that, in adrenalectomized rats, a low-dose glucocorti-
coid substitution is a necessary requisite for the occurrence of compen-
satory adaptation following unilateral nephrectomy. Furthermore, they
suggest that a positive acute Na balance is not required for triggering off
the adaptive response.
Acute renal failure following multiple trauma. A. Kunz and U.
Binswanger. Nephrologische Station, Deparlement Innere Medizin,
Universität Zurich, Zurich, Switzerland. Between January 1976 and
June 1981 19 patients suffering from post-traumatic acute renal failure
were treated by hemodialysis at least three times a week, sometimes
daily. Their multiple injuries were classified as proposed by the
Abbreviated Injury Scale (AIS) and the overall severity of trauma for
each patient was computed with the Injury Severity Score (ISS). On
admittance to the hospital ten patients had an ISS with a statistical
mortality risk of 50% or higher, nine were in the range of 25 to 45%. In
addition to trauma and acute renal failure, all patients suffered from
various complications, most often hypovolemic shock (15/19) and
sepsis (13/19). The overall mortality within 12 months from trauma was
a discouraging 84% (16/19) with a mean survival time of 32 days. All but
one death occurred before recovery of renal function. Together with the
initial trauma, sepsis accounted for nine of all fatal outcomes, cerebral
or cardiovascular complications for five. In two patients the cause of
death was not clearly defined. The three survivors were among the
severely injured and two also had sepsis. The high mortality in this
group of patients is due mainly to the extent of injury and to the
occurrence of life-threatening post-traumatic complications. Whether
these basic problems are aggravated by renal failure or not, the overall
results of the treatment success claim for careful definition of indica-
tions for laborious and expensive therapeutic measures.
Evaluating 4-year CAPD program. F. Louis and H. Favre, Division of
Nephro!ogy, Hôpital Cantonal Universitaire, Geneva, Switzerland.
Thirty-five patients (30 men and 5 women aged from 33 to 78 years;
mean age, 55 years) with endstage renal disease (ESRD) were treated
by CAPD. The total survival rate was 86, 65, 65, and 48%, respectively,
at 1, 2, 3, and 4 years and 93, 75, 75, and 56% when diabetic patients
were excluded. Four patients received a kidney graft (11.5%) and five
others were transferred to hemodialysis (14%) for recurrent peritonitis.
Blood pressure (BP) was adequately controlled in 80% of the patients,
with or without moderate hypotensive medication. Twenty percent of
the patients required an increase in their drug regimen while on CAPD.
Rehabilitation was evaluated according to a scoring system rating from
one to four. Scores 4, 3, 2, and I were found in 54, 26, 14, and 5.7%,
respectively, of the patients. Hematocrit (Ht) remained spontaneously
stable at 30.9 0.008% with the exception of three patients who
received occasional blood transfusions. Peritonitis occurred at a mean
rate of 1.9 year per patient with 18 patients having less than two
peritonitis episodes during their whole treatment on CAPD. Most of the
patients received ambulatory care for their peritonitis. No deaths
occurred for this reason. Mean hospitalization duration was 10.5 days
per year per patient. In conclusion, this CAPD program has provided
excellent rehabilitation, facilitated the control of BP and Ht in nondia-
betic patients. By contrast, it was a failure in diabetic patients.
Interesting to note is the very short duration of hospitalization in this
population of ERSD patients.
Effects of three pressor agonists on renal prostaglandins. R. Loup, L.
Favre, C. Wicht, and M. B. Vallotton. Division d'Endocrinologie,
Hôpital Can tonal Universitaire, Genève, Geneva, Switzerland. Animal
studies have shown that renal prostaglandins (PG) participate in the
vasodilatory mechanisms protecting against vasoconstrictive influ-
ences. To evaluate the effects of pressor agonists on renal PG in
humans, seven healthy female subjects received 3-hr graded infusions
of norepinephrine (NE) (20, 100, and 200 nglkg/min), vasopressin (AVP)
(0.2, 1, and 2 ng/kg/min), and angiotensin II (ALL) (I, 5, and 10
ng/kg/min). PGE2, F2a and 6-keto-FI a, the stable metabolite of prosta-
cyclin, were measured in urine by radioimmunoassay. NE and All
increased the systolic and diastolic blood pressure, and AVP only the
diastolic pressure. Pulse rate was reduced by NE and All. An antidi-
uretic effect was observed during AVP and All infusions, associated
with a rise in urinary osmolality and a drop in plasma osmolality. PRA
was inhibited by All and not modified by NE and AVP. Urinary PGE2
tended to rise with NE and AVP, but the changes were not significant.
Urinary PGF2a rose with the maximal dose of NE (19 5 to 88 25
ng/hr; mean sEM; P < 0.05), AVP (16 3 to 38 4; P < 0.05), and
All (20 3 to 48 II; P < 0.05). The rise in diastolic pressure
significantly correlated with the change in PGF2a during NE (r = 0.45,
P < 0.05) and All (r = 0.57, P < 0.05) infusions, but not during AVP
infusion (r = 0.25, NS). Urinary 6-keto-Fla increased from 4.5 1.2 to
13.4 3.6 ng/hr (P <0.05) during AVP infusion, and from 5.7 1.6 to
18.7 4.8 (NS) during NE infusion. No change occurred with All. In
conclusion, the renal vasoconstriction induced by pressor agonists
resulted in a predominant release of PGF2a and 6-keto-PGFIa. While
the order of potency in terms of pressor effect at the doses selected was
NE = All <AVP, in terms of PGF2a it was NE> AVP = All, and in
terms of 6-keto-Fla, AVP > NE > All, underscoring the differing
behavior of these renal PG.
Stimulation of prostaglandin E2 from superfused rat renal medullary
cells by three vasoactive peptides: role of calcium. R. Loup, B. C.
Williams, L. Favre, C. Wicht, and M. B. Vallotton. Division d'Endo-
crinologie, Hôpital Cantonal Universitaire, Genève, Geneva, Switzer-
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land. Prostaglandin (P0) synthesis is known to be a calcium (Ca')-
dependent process. To assess the role of Ca in the stimulation of
PGE2 by vasoactive agents, rat renal medullary cells were superfused in
the presence ofangiotensin ii (ANG II), bradykinin (BK), or vasopres-
sin (AVP) with or without verapamil(V), Ca, or lanthanum (L). After
dispersion by collagenase, medullary cells were introduced into Teflon
columns and superfused with KRBB containing 2 x 10-2 M glucose and
l0 M arachidonic acid with either l0- M EGTA or 2.5 x l0- M
CaCl2. The stimuli (l06 M) were applied for 10 mm at 30 mm-intervals
at 3TC. PGE2 production was determined by RIA. BK induced a 1.4-
fold increase of PG release, AVP a 4.7-fold, and ANG ii a 5.6-fold. V
(106 M) or L (l0- M) added prior to and concomitant with the stimuli
did not significantly modify the responses. in absence of Ca PGE2
response to ANG II and AVP was decreased by 3.9- and 3.5-fold. In
conclusion, the three vasoactive agents tested have a direct effect on
the release of POE, by medullary cells with the following order of
potency: BK<AVP<ANG II. The response of PGE2 is reduced in
absence of extracellular Ca, but is not affected by V or L. These
results confirm that PG synthesis is a Ca**dependent process, al-
though a Ca*+ influx through voltage-dependent channels seems not to
be an absolute requirement for PG stimulation by these peptides.
Systemic availability of total and unbound prednisolone after intrave-
nous prednisolone sodium phosphate, intravenous prednisolone sodium
phthalate or oral prednisone in renal transplant patients with acute
rejection. F. J. Frey, B. M. Frey, M. Seeberger, and J. Hodler.
Medizinische Poliklinik, Departments of Clinical Pathology and Clini-
cal Pharmacology, University of Bern, Switzerland. Renal allograft
rejections are usually treated with high doses of prednisone (P) or
prednisolone (Po). The solubility of the biologically active Po is poor.
Therefore Po is administered intravenously as prednisolone sodium
phosphate (Pop) or as prednisolone sodium phthalate (Poph). The time
course of hydrolysis of high doses of these two prodrugs has not yet
been investigated. Similarly the interconversion of high doses of oral P
into Po has not been investigated. Therefore ten patients treated for
acute rejection were investigated. All subjects were given randomly on
three occasions either oral F, intravenous Pop, or intravenous Poph in
equimolar doses corresponding to 7 mg/kg of Po. Following dosing,
blood samples were collected over a 24-hr period. Total Po and P
concentrations and the unbound fraction of Po were assessed by HPLC
and equilibrium dialysis. The time of peak concentrations of total and
unbound Po were determined and the area under the plasma concentra-
tion versus th time curve of total (AUCT) Po and P and of unbound
(AUC) P0 were calculated. The results (x SD) were the following:
Prednisolone
Time to peak,
P0-Phosphate, Po-Phthalate,
i.v. i.v.
mm 25 9 69 42 217 194
18.4 3.4 2.9 0.5 3.1 0.8
9.9 1.3 1.3 0.4 1.3 0.3
2324 683 1209 324 1584 556
These results indicate that (I) the systemic availability of Po after oral P
or intravenous Poph is lower than after intravenous Pop (P < 0.001); (2)
the hydrolysis of the phosphate ester is faster than of the phthalate
ester; (3) part of the Poph is eliminated without prior biotransformation
into systemically available Po or P; (4) the interconversion of P into Po
does not seem to be a rate-limiting step, since the differences in AUC of
P after oral P and intravenous Pop do not explain differences in AUCs
of Po.
Antihypertensive therapy with the calcium antagonist nifedipine alone
or combined with a diuretic: responses of the body sodium-blood volume
state and some other pressor factors. C. Marone, S. Luisoli, F. Bomio,
C. Beretta-Piccoli, M. G. Branchetti, and P. Weidmann. Ospedale San
Giovanni, Bellinzona, and Medizinische Poliklinik, University of Berne,
Switzerland. Calcium antagonists may interact with several blood
pressure-regulating mechanisms, but their effect on body sodium is
largely unknown. Therefore, total exchangeable sodium and blood
volume (by isotope dilution method using 24Na and '311-human serum
albumin), plasma epinephrine, norepinephrine (by radioenzymatic as-
say), renin and aldosterone levels (by radioimmunoassay) were mea-
sured in ten patients with essential hypertension on placebo. Following
6 to 8 weeks of monotherapy with nifedipine (NIF), 3 x 10 to 20
mg/day, and after an additional 6 to 8 weeks on NIF combined with the
diuretic chlorthalidone (CHLOR), 25 to 50 mg/day. Supine blood
pressure was decreased from IS 1/97 5/2 (5EM) to 132/88 6/2mm Hg
after NIF alone (P < 0.05) and to 124/83 7/3 mm Hg after NIF +
CHLOR (P < 0.01). Body weight was increased from 72.7 to 73.9 kg on
NIF alone (P < 0.05), but decreased to 72.1 (P < 0.05 compared with
placebo) after adding CHLOR. Exchangeable sodium also rose from
2642 237 to 3360 266 mEq on NIF (P < 0.05) and returned to
control values (2638 248 mEq) after addition of CHLOR. Blood
volume was not significantly altered on NIF (from 4210 303 to 4279
253 ml), but was reduced to 3969 333 ml on NIF + CHLOR (P <
0.05). Heart rate, supine and upright plasma renin, aldosterone, and
catecholamine levels were not consistently changed on NIF alone or
combined with CHLOR. These findings indicate that mild sodium
retention may develop after short-term monotherapy with NIF at least
in some hypertensive patients. The addition of a thiazide diuretic may
restore body sodium, slightly reduce blood volume and thereby comple-
ment the blood pressure-lowering effect of a calcium antagonist therapy
with NIF in essential hypertension.
Monoclonal antibodies against angiotensin II. J. Nussherger, G.
Matsueda, and E. Haber. Cellular and Molecular Research Labora-
tory, Cardiac Unit, Massachusetts General Hospital and Harvard
Medical School, Boston, Massachusetts. Angiotensin antisera identify
immunoreactive angiotensin rather than absolutely discriminating be-
tween the different angiotensins. Theoretically, a monoclonal antibody
Sclerosing peritonitis in a child on CAPD. C. A. Mayor, M. Tsourouk-
dissian, and f-P. Guignard, Service de Pédiatrie, CHUV, Lausanne,
Switzerland. A 10-year-old child presented with terminal renal failure
secondary to reflux nephropathy. Because of repeated failures of
establishing an arteriovenous fistula, he was started on CAPD. A
catheter (Tenckhoff) was used for access to the peritoneal cavity. Four
I-liter exchanges were performed daily, three of them with an isotonic
solution, one of them with an hypertonic solution (dialysate composi-
tion: Na 134, Mg 0.5, Ca 1.75, Cl 103.5, lactate 35 mmoles/liter with
either 1.5 or 4.25% glucose). During the first 18 months of treatment,
the patient presented with seven episodes of peritonitis. A concomitant
progressive decrease in ultrafiltration efficiency was noted. Escherichia
coli (2 x) and Staphylococcus epidermidis (4 x) were isolated in the
Oral first six episodes of peritonitis. No germ could be isolated on the
prednisone seventh episode which was characterized by severe abdominal pain,
intestinal paralysis, drainage difficulties, and cloudy dialysate. lntra-
peritoneal antibiotherapy with tobramycin and vancomycin did not
improve the condition of the patient. The catheter was removed and the
patient put on hemodialysis, using a subclavian double lumen catheter.
Six weeks later, the patient was returned on CAPD, and a disc catheter
(Life Cath, Physio-Control) was chosen for access to the peritoneal
cavity. At operation, the peritoneal membrane was grossly thickened,
and encased all the bowel loops in an orange-like mass. CAPD was
resumed; dialysis remained effective, but the ultrafiltration efficacy
further decreased. Several episodes of nausea, vomiting, malabsorp-
tion, and peritoneal bowel obstruction occurred in the following
months. The patient was transferred to hemodialysis, and eventually
died of cardiac tamponade during an heniodialysis session using a
subclavian catheter. A variety of insults (chemicals, temperature,
infections, and so forth) may probably induce inflammatory reaction
with progressive thickening of the peritoneal membrane. The precise
pathogenesis of this condition which may have distressful conse-
quences remains however unknown.
Peak cone, total,
sg/ml
Peak conc. un-
bound. ttg/mI
AUCT,
,ug/ml/min
AUC1,
p.g/ml/inin
Prednisone
AUCT,
jig/mI/mm
1138 352 593 210 656 204
34.5 13 27.4 14 48.8 IS
Abstracts 987
could have such a discriminating capacity. Nine CAF1/J mice were
immunized intraperitoneally (i.p.) with All coupled by its carboxy-
terminal to thyroglobulin. Antigen (100 g) was given twice at a 6-week
interval. Individual mouse sera were screened for the binding of 125j
All using charcoal to separate antibody-bound from free tracer. Mice
with significant antibody production were hyperimmunized on 3 con-
secutive days and the spleen was removed on day 4. The spleen cells
were incubated with lipopolysaccharide and fused with SP 2/0 myeloma
cells using polyethylene glycol (1000 daltons). To screen the hybrid
cells for antibody production, plastic wells were coated with All, then
cell supernatant was placed in the wells and finally radiolabeled goat
anti-mouse Fab was added. After washing, each well was counted in a
gamma-counter. The best clones were propagated and injected into
Pristane pretreated CAF1/J mice. Ascites of such treated mice provided
antibodies specific for the angiotensin-(3-8) hexapeptide with a 16%
crossreaction with All and 19% with Alll in a radioimmunoassay
(RIA). No crossreaction was found with Al. A 50% tracer displacement
in the RIA was obtained with 200 nsi angiotensin. In seven fusions,
hybrid growth was found in 90% and antibody production in 42% of all
wells. Thus, it is possible to obtain antibodies against All by the
hybridoma method. The initial antibodies did not express the desired
specificity, but it is hoped that future clones may differentiate between
All and its metabolites with a high degree of resolution.
Hemodialysis—no reason to give up driving. F. Spertini, J. P.
Wauters, J. Stroun. and M. F. Beck. Division de Nephrologie, Hôpital
Universiraire, Lausanne, and Verkehrpsychologisches Institut, Bern,
Switzerland. To evaluate the ability of chronically hemodialyzed pa-
tients to drive a car, the concentration, attention, and decision capacity
was measured before and after a dialysis session. The study group
(group I) consisted of 19 patients (12 male, 7 female) aged between 23
and 66 years (mean, 52 years), treated by center hemodialysis (3 x 3 hr
week) for at least 3 months (mean, 51); 12 were taking antihypertensive
and two sedative drugs. Their results were compared to those of 19
normal subjects (6 male, 13 female; mean age 36; group 2) before and
after a 3-hr interval of normal activity. The reaction time to sound and
light, the mean choice reaction time (CRT, time to make a decision
among sound and colors of a flashing panel), the individual CRT SD and
the tensor time (time to rank mixed signs) were measured. In group I no
significant difference was observed before and after dialysis for mean
reaction time to sound (212 34 vs. 212 47 mm) (mean 1 SD), CRT
(372 53 vs. 369 42 mm), individual CRT SD (101 26 vs. 95 25
mm) and tensor time (7.0 1.9 vs. 6.7 1.9 mm). Moreover, no
significant difference was observed between groups 1 and 2 for all
parameters except reaction time to light. Individual CRT SD, the
parameter exhibiting the closest correlation with car accidents (P <
0.01), was not different at any time between the 2 groups. In conclusion,
concentration, attention, and decision capacity of chronically hemodia-
lyzed patients seems to be normal and is not altered by the dialysis
session. Within the limits of this test, hemodialysis per se does not
appear to increase the risk of causing a car accident. The decision to
dissuade some hemodialysis patients from driving should be based on
individually defined risk factors.
Evaluation of ureteric obstruction in renal transplant recipients by
percutaneous nephropyelostomy and ureteral perfusion (Whitaker test).
C. L. Zollikofer, U. Keusch, W. F. Brühlmann. D. Baumgartner, H. R.
Burger, F. Largiadèr, and U. Binswanger. Departments of Diagnostic
Radiology, Internal Medicine, Pathology and Surgery A, University of
Zurich, Zurich, Switzerland. The diagnosis of functional relevant ure-
teric obstruction in renal transplant recipients can present a diagnostic
problem with standard methods. We therefore have extended the
technique of percutaneous nephropyelostomy to the evaluation of
obstruction in renal transplant recipients. Antegrade pyelography (AP)
and percutaneous nephrostomy (PN) were performed in 14 patients
(seven males, seven females; age, 12 to 58 years; mean, 38 years) with
suspected obstruction on IVP, retrograde pyelography or ultrasound.
Eleven patients had renal biopsies (Bx). In ten of 14 patients PN-
drainage was performed because of marked stenosis on AP or positive
Whitaker test (WT). A WT performed in eight patients ruled out
obstruction in two. In another two patients obstruction was ruled out
with AP alone. Three patients with marked obstruction showed rapid
fall in serum creatinine (S.) with drainage and/or operation. Bx in these
patients showed interstitial edema but no fibrosis or rejection. In five
patients Sc increased steadily despite drainage and surgery. Bx in these
patients showed marked interstitial edema with interstitial fibrosis.
Despite marked obstruction AP showed no or only mild dilatation of the
pelvicalyceal system, and ultrasound performed in three patients
showed no signs of obstruction. From our results we conclude that AP
and the WT are superior to IVP, retrograde pyelography, or ultrasound
in making a fast and safe diagnosis of ureteral obstruction. Rapid fall in
Scr with drainage and Bx showing no signs of interstitial fibrosis seem
to be valuable prognostic parameters. If obstruction is suspected on the
basis of standard investigations, this should be verified by AP and WT
with immediate drainage even in the presence of normal Scr levels since
prognosis seems to be much more favorable as long as interstitial
fibrosis has not developed.
A toad kidney epithelial cell line (A6); A suitable experimental model
for studying the late mineralocorticoid response with regard to sodium
transport and (Na, K)ATPase biosynthesis. M. P. Paccolat, K.
Geering, H. P. Gaeggeler, and B. C. Rossier. Institut de Pharmacolo-
gie, Université de Lausanne, Lausanne, Switzerland. Measured by the
short circuit current (SCC) method, the typical time course of aldoster-
one-induced Na transport across the amphibian urinary bladder and
related epithelial can be divided into three phases: a latent period (—45
mm), an early response (—2 hr) characterized by a rapid increase of
SCC with a concomitant fall of transepithelial electrical resistance (R),
and a late response (—4 hr) showing a further increase of SCC without
any significant change of R. This late response is also characterized
biochemically by a two- to fourfold increase in the biosynthesis rate of
the (Na, K)ATPase. The A6 epithelial cell line forms a high R
monolayer in culture with the following electrical base line values: a
very low potential difference (PD) (0 to 0.8 mV) but a high R (2500-3500
fl cm2) and a small or undetectable SCC (0 to 0.2 A/cm2). Examining
its 24-hr electrophysiological response to aldosterone (100 nM), we
observed (1) a prolonged latent period (up to 3 hr) followed by (2) a 12-
fold increase of PD (P < 0.001) and a sixfold increase of SCC (P <
0.001) with a concomitant threefold increase of R (P <0.00 l)(Ncontroi =
9, N = 43). Moreover, the A6 biochemical response preceded by
about 1.5 hr the SCC response and displayed a three- to sixfold increase
in the (Na, K)ATPase a-subunit relative rate of biosynthesis. Both
effects on SCC and (Na*, K)ATPase biosynthesis were fully revers-
ible on washout of the hormone within 24 hr. The effects of aldosterone
on 5CC, PD, R, and a-subunit biosynthesis were dose-dependent
within 1-100 n concentrations. Dose responses were parallel but not
superimposed, suggesting the existence of at least two types of recep-
tors in this cell line. The described A6 cell line response to aldosterone
mimicks part of the characteristic late response observed in the intact
tissue and should therefore help us to understand the molecular events
specifically involved in this response.
Working capacity in patients treated with hemodialysis (HD) and
continuous ambulatory peritoneal dialysis (CAPD). G. Keusch, E. Luthy,
T. Jenni, R. Tartini, H. Rölli, W. Steinhrunn, and U. Binswanger.
Nephrologische Station und Abteilung für Kardiologie. Departement
für Innere Medizin, Universitatsspital, Zurich, Switzerland. To evalu-
ate the degree of physical activity in patients treated with HD and
CAPD, we assessed the working capacity (WC) by bicycle ergometry
(BE) in 16 patients treated with HD [mean age, 47 12 (SD) years] and
18 patients treated with CAPD (mean age, 44 10 years). In CAPD-
treated patients WC was measured in addition to BE with treadmill
exercise (TE).
Results
(Mean SD):
HD
BE
CAPD
BE TE
WC, watt 58 31 69 40 76 52
WC, % of normal
values 41 24 52 25 56 33
Specific WC, watt/kg 0.82 0.49 1.09 0.61 1.20 0.82
Duration of exercise,
mm 4.9 2 6.1 2.0 5.2 3.2
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In 12 of 16 HD patients and 15 of 18 CAPD patients WC was greater
than 25% of age- and sex-matched normal values. Exercise testing had
to be discontinued because of the following reasons: HD-patients: leg
fatigue, 10; general fatigue, 3; dyspnea, 1; reaching maximum heart
rate, 2; CAPD-patients: leg fatigue, 10; reaching maximum heart rate, 3;
claudicatio interm, 2; angina pectoris, 1; others, 3. A positive correla-
tion between WC and serum creatinine levels was found in HD-patients
(r = 0.62, P < 0.01) and CAPD patients (r = 0.42, P < 0.05). In CAPD
patients only a positive correlation between WC and hemoglobin level
(r = 0.68, P < 0.01) was found. In conclusion, an acceptable degree of
WC (> 25% of normal values) was found in most dialysis patients
(27/34) either treated with HD (12/16 patients) or with CAPD (15/18
patients). There was no significant difference in WC between HD and
CAPD treatment.
Verapamil does not protect from acute ischemic renal failure in rats. H.
A. Bock, S. Bertschin, F. P. Brunner, and G. Thiel. Departemen! für
Innere Medizin, Kantonsspital Base!, Base!, Switzerland. Recent ex-
perimental work in animals suggests a protective effect of calcium
antagonists on norepinephrine-induced and ischemic acute renal failure.
In most of these studies renal failure was induced unilaterally with the
contralateral kidney serving as control. This approach has inherent
limitations, as the undamaged kidney is expected to compensate for the
systemic effects of acute renal failure, thereby influencing outcome. We
tried to find a protective effect of verapamil on acute ischemic renal
failure using a one-kidney model. Female Wistar rats were unilaterally
nephrectomized at least 2 weeks before experiments. lschemic renal
failure was induced by clamping of the remaining renal artery for 60 mm
at 37°C. Immediately prior to induction of renal failure the infrarenal
aorta was occluded for 2 mm, during which time verapamil, 0.1 mg/kg
(group A), 1.0 mg/kg (group B), dissolved in 0.9% saline or 0.9% saline
alone (group C) was slowly injected into the suprarenal aorta. Urine
volume and C. were followed for 48 hr after renal artery occlusion.
Oliguric renal failure developed in all three groups. There were no
significant differences between the two verapamil groups (A and B) and
control rats (C) in terms of urine volume, serum creatinine, or C..
Values of Cc, are summarized below (1dlmin!l00 g wt, mean +1— SEM,
upper 95%-confidence-limits (CL) for the two verapamil groups using
logarithmic transformation of data):
Control
Group day 24 hr CL 48 hr CL
A Verapamil,
0.1 mg/kg (N = 9) 528 +1— 25 10 +1— 3 12 13 +1— 3 16
B Verapamil,
1.0mg/kg (N 8) 431 +1—34 27+!— II 43 33 +/— 12 46
C 0.9% NaCI (N = 10) 430 +1— 31 37 +1— 19 41 +1— 20
We conclude that verapamil has no protective effect on acute renal
failure in this animal model.
Spontaneous arteriovenous hemofiltration in the treatment of acute
renal failure. N. Hofliger, G. Keusch, and U. Binswanger. Nephrolo-
gische Station, Departement für innere Medizin, Universitdt Zurich,
Zurich, Switzerland. Spontaneous arteriovenous hemofiltration(SAVH) is a simple technique in the treatment of acute renal failure
(ARF). We analyzed 19 intensive care patients [mean age, 52 15 (SD)
years], who were treated with SAVH for ARF. The causes of ARF were
as follows: postoperative ARF in ten patients; post-septicemic ARF in
six patients; miscellaneous in three patients. Fifteen patients were
oliguric and four patients were nonoliguric with a mean daily urine
output of 958 372 ml, respectively. At the start of SAVH the serum
creatinine level was 561 153 moles!liter. The duration of treatment
with SAVH was 2 to 36 days (10.4 8.8 days). The extracorporeal
circulation was performed by cannulation of the femoral artery and vein
in 18 patients and by a Scribner shunt in one patient. After an initial
systemic dose of 2000 IU heparin a continuous infusion of 250 to 1000
lU/hr into the arterial blood line was administered adjusted to a partial
thrombine time of SI 12 sec. With this heparin regimen a single
hemofilter could be used for an average time of 2.9 1.4 days. The
mean spontaneous filtration rate was 7.12 3.3 mI/mm resulting in the
following serum levels: creatinine 514 166 smoles!liter; urea 36
12.4 mmoles/liter; potassium 4.4 0.43 mmoles/liter. Coagulation
occurred in 38 hemofllters and ruptures in four. Occluding venous
thrombosis with pulmonary emboli was observed in one patient. Six
patients recovered kidney function and survived. In conclusion, the
most important potential of SAVH was its simplicity, an optimal control
of fluid balance, and the possibility of unlimited parenteral nutrition.
Uremia was adequately and continuously controlled. Prognosis of ARF
was related to the underlying illness of the patients.
Long-term follow-up of renal function after corrective surgery of severe
hydronephrosis. M. Sommer, N. Genton, and J. P. Guignard, Depart-
ments of Pediatric Surgery and Pediatrics, Lausanne, Switzerland.
Severe hydronephrosis due to congenital chronic urinary tract obstruc-
tion or primary vesico-ureteric reflux is often associated with a progres-
sive deterioration of renal function in infants and children. Obstruction
can be relieved and reflux abolished by various surgical procedures.
This study defines the long-term outcome of renal function in children
operated on at various ages. Forty-one patients presenting with severe
hydronephrosis and/or chronic renal insufficiency were included in the
study. Corrective surgery was performed before 1 year of age (group 1),
between the age of I and 2 years (group 2), and after 2 years (group 3).
When present, urinary tract infection was treated and patients were
given prophylactic antibiotherapy. Renal function was assessed pro-
spectively at I to 2 year intervals, using creatinine and/or inulin
clearances. The follow-up period after reconstructive surgery was I to
19 years. A progressive deterioration of renal function was observed in
9 of 22 patients of group I, 5 of 6 patients of group 2 and 6 of 13 patients
of group 3. Seven out of 41 patients reached terminal renal failure 4 to
16 years after diagnosis of the condition. No significant difference was
observed between patients presenting with obstruction and those
presenting with reflux. In two children of group I, a decrease in GFR
could be observed after a transient normalization of GFR. In all
patients, the deterioration of renal function occurred in the absence of
risk factors such as infection, persistence of obstruction or reflux. or
hypertension. In a third of the patients, the deterioration was associated
with the appearance of significant proteinuria. The most important
prognostic factor in these children appeared to be the level of remaining
functional renal mass at the time of operation. The adaptive hemody-
namic changes occurring in remaining nephrons probably contribute to
the ultimate destruction of surviving glomeruli, thus leading to progres-
sive renal failure.
Prevention of kidney scars by suppression of the acute inflammatory
response to infection during experimental acute exudative pyelonephritis
(AEPN). J. Bil!e and M. P. Glauser, CHUV, Lausanne, Switzerland. To
study the relations between acute renal infection and subsequent kidney
scar (CPN) formation, we used a rat model of unilateral ascending
Escherichia co/i obstructive pyelonephritis, mimicking complicated
urinary tract infection in humans. To establish whether kidney scars are
the late consequence of kidney infection or the result of inflammation
and suppuration elicited by bacterial multiplication in the kidney, we
administered antibiotics or anti-inflammatory agents at the early stage
of AEPN. Antibiotics were effective in preventing kidney damage only
when given very early, at least before inflammation was fully estab-
lished. Beyond that time antibiotics were not able to prevent kidney
scars, even if they eradicated bacteria from the kidney. Anti-inflamma-
tory agents acting on polymorphonuclear leukocyte (PMN's) function
(colchicine) or neutropenia (cyclophosphamide-induced) protected
against scar formation to the same extent, suggesting that PMN's
played a major role in the pathogenesis of scar formation. This
protection was afforded whether bacterial numbers in the kidney
parenchyma were lowered (in the antibiotic experiments), or increased
(in colchicine- and cyclophosphamide-treated rats) suggesting that the
development of kidney scars was rather independent of infection. In all
experiments, the protection against scar formation was in direct relation
to the diminution of inflammation during the acute phase. These
experiments therefore strongly suggest that chronic pyelonephritis and
scar formation are mainly the result of early kidney damage through
inflammatory processes secondary to infection and not the result of
infection per se or of an immunological process.
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Renal handling of norepinephrine and epinephrine in the pig. L. Link,
P. Weidmann, P. Probst, and A. Futterlieb. Medizinische Poliklinik,
University of Bern, Bern, Switzerland. The adrenergic system may have
important effects on kidney function. However, information on the
renal handling of catecholamines is scarce and limited to few species
such as the chicken, rat, rabbit, and dog. To further study this aspect in
mammals, seven anesthetized female baby pigs were investigated.
During a constant intravenous infusion of 51Cr-EDTA and PAH,
samples for simultaneous measurement of norepinephrine (NE), epi-
nephrine (E), 51Cr-EDTA and PAH were obtained through catheters
placed into the aorta (A), renal vein (V), and both urethers. Glomerular
filtration rate C'Cr-EDTA clearance) averaged 22 9 (+sD) mI/mm; A-
V extraction of PAH was 0.87 0.09 and calculated total renal plasma
flow 80 30 mI/mm. The results of the catecholamine studies are
shown in the table below.
Plasma Concentration A.V extraction Transrenal Urinary Net renal
A v ratio extraction rate excretion rate secretion rate
pg/mi nglmin
NE 159±95 06±88 0.36±0.19 5.2±3.9 8.9±4.3 3.7±4.4
E 46±23 12±12 0.77±0.20 3.6±3.8 2.9±2.0 —0.7±2.48
These observations suggest that in pig kidneys (1) plasma PAH is
extracted at about the same rate as in human kidneys, (2) three quarters
of circulating E are extracted, and the slightly smaller amount appearing
in the urine is consistent with some intrarenal metabolism and tubular
secretion, and (3) NE presumably originating from intrarenal neural
release and/or de novo production is secreted into the urine, since
urinary NE excretion markedly surpasses net renal extraction rate.
Transport of adenosine by kidney brushborder vesicles. M. Le Hir, U.
C.Dubach, Medizinische Universitats-Polik!inik, Kantonsspital, Base!,
Switzerland. Adenosine (ADO) seems to be an important physiological
regulator of kidney function. It depresses glomerular filtration probably
by increasing the resistance of the afferent arterioles. It may play a role
as transmitter in the tubuloglomerular feedback. Therefore, it seems
important to study the renal handling of ADO. We investigated a
possible mechanism for the reabsorption of ADO in the proximal
tubule: The transport of (3H) ADO into brushborder vesicles of the rat
kidney was studied by a rapid filtration technique. Three components of
the uptake of ADO were observed: (I) binding to the membrane, (2)
transport across the membrane, and (3) metabolism. Binding to the
membrane and transport are stimulated by Na. In the presence of a
gradient of Na° (out > in), but not of K, the intravesicular concentra-
tion of unmetabolized ADO exceeds (three- to fivefold) transiently the
intravesicular concentration. An apparent Km of 1.1 sM has been found
for the transport of ADO in the presence of 100 mi NaCI. The transport
of ADO was inhibited by inosin, guanosin, 2'-deoxyadenosin and 2-
chloradenosin in the low micromolar range. Inosin was the main
product of the intravesicular metabolism of ADO. In conclusion, we
demonstrated the existence of a Na-dependent mechanism for uphill
transport of ADO at the luminal membrane of the proximal tubule. Its
Km is close to the physiological concentration of ADO in serum. This
transport mechanism seems therefore capable of removing ADO from
the primary urine.
Blockade of the vascular effect of vasopressin in normal volunteers. J.
P. Bussien, B. Waeber, J. Nussberger, M. D. Schaller, K. Hofbauer,
and H. R. Brunner. Division of Nephro!ogy and Hypertension. Centre
Hospitalier Universitaire, Lausanne, Switzerland. The role of arginine
vasopressin (AVP) in maintaining blood pressure was investigated in
healthy normally hydrated volunteers using d(CH2)5Tyr(Me)AVP, a
potent specific inhibitor of the vascular effect of AVP. This antagonist
was first tested in four subjects at a dose of 5 jsg/kg i.v. and shown to
antagonize for at least 2 hr the blood pressure, heart rate, and skin
blood flow response to lysine-vasopressin infusion (I mUI/kg/min for 5
mm). Skin blood flow was determined with a flowmeter. The same dose
of d(CH2)3Tyr (Me)AVP was then administered at a I-week interval to
ten subjects 60 mm following an oral dose of either captopril (25 mg) or
a placebo. This study was conducted in single-blind fashion with
random allocation of treatment order. The AVP-antagonist had no
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effect on blood pressure, heart rate, or skin blood flow even after acute
blockade of the renin system. Angiotensin converting enzyme inhibition
with captopril reduced plasma angiotensin II levels but had no influence
on circulating AVP. Plasma catecholamines and angiotensin II levels
remained unchanged following d(CH2)5Tyr (Me)AVP. It appears there-
fore that AVP does not participate in blood pressure maintenance of
normally hydrated normotensive subjects with or without an intact
renin-angiotensin system.
The long-term effects of captopril on renal function in hypertensive
patients. Z. G!ück, C. Beretta-Piccoli, and F. C. Reubi. Medizinische
Poliklinik der Universität Bern, Bern, Switzerland. The effects of
captopril in daily doses up to 450 mg on blood pressure and renal
function were investigated under sustained treatment in ten patients
whose severe hypertension did not respond to previous therapy. All
patients were kept on diuretics and most of them on 1.3-blockers. A
control determination of glomerular filtration rate (GFR) and PAH
clearance (CPAH) was performed under previous treatment. The effects
of the addition (or substitution) of captopril were assessed after an
average of 25 days (short-term) and 26 weeks (long-term). Short-term
treatment produced a 15.5% decrease in mean blood pressure and
interindividually variable effects on renal function. On the average,
GFR was somewhat lower and CPAH slightly higher than the control
values (not significant). Under long-term conditions GFR rose by a
mean of 9% (NS) and CPAH by 17% (P < 0.02). However, in a patient
who developed a captopril-induced nephrotic syndrome, GFR dropped
to 56% and CPAH to 50% of the control values.
Rapidly progressive glomerulonephritis associated with Legionnaires'
disease. E. Wegmililer, P. Weidmann. T. Hess, and F. C. Reubi.
Medizinische Polik!inik, University of Bern, Bern, Switzerland. Legion-
naires' disease (LD) commonly causes pulmonary manifestations, but
multisystem involvement of the kidney, liver, gastrointestinal tract, and
nervous system also may occur. Occasionally, transient impairment of
kidney function and even terminal renal failure have been observed.
Renal histology which was examined in some patients consistently
revealed acute or chronic interstitial nephritis, probably caused by the
Legionella pneumophila infection. We describe the case of a 52-year-
old man with a rapidly progressive glomerulonephritis in association
with LD and who previously had a normal kidney function and urine
analysis. He presented with severe pneumonia and acute oliguric
kidney failure, not related to hypotension or nephrotoxic drugs. The
diagnosis of LD was based on a six-fold rising titer of antibodies against
L. pneumophila (serogroup 4), as detected by indirect immunofluores-
cence. The renal biopsy specimen showed a severe crescentic glomeru-
lonephritis with diffuse intracapillary proliferation and only slight
interstitial lesions. Granular deposits of C3 in the capillaries and of
fibrinogen in the crescents could be detected by immunolluorescence.
The search for L. pneumophi!a antigen within the glomerula or the
interstitium was negative. Treatment with erythromycin resulted in a
clinical recovery of pulmonary manifestations after 8 weeks. However,
the impairment of kidney function was progressive and lead to terminal
renal failure, requiring long-term hemodialysis. This observation sug-
gests that acute glomerulonephritis should be included in the list of
possible renal complications of Legionnaires' disease.
Rapid adaptation of phosphate (Pi) transport to one low Pi meal in rat
cortical brush border membrane vesicles (BBMV). J. Caverzasio and J.-
Ph. Bonjour, Division de Physiopathologie, Department de Médecine,
Hôpital Cantonal Universitaire, GenCve, Geneva, Switzerland. The
adaptive response of tubular P1 transport to Pi deprivation in whole
kidney is present 24 hr after switching rats from high (HDP) to low
(LPD) Pi diet. We have studied whether an earlier response of sodium-
dependent Pi transport (Na-PiT) can be detected in BBMV. Rats were
trained to eat the daily food ration in 2 hr, and then either maintained
under HPD (0.8%) or switched to LPD (0.2%). Two and four hours after
the meal, rats were either sacrificed for BBMV isolation or used for
determining urinary (UPi/mI GF) and plasma Pi (PlPi). The results were
2 and 4 hr after the meal, BBMV Na-PiT increased by more than 50 and
100%, respectively, in intact rats exposed for the first time to LPD. This
response was associated with a significant fall in PIPi (HPD: 2.50 0.04
LPD, 2.14 0.07 mM) and in UPi/mI GF (HDP: 0.976 0.035, LPD,
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0.010 0.006 zmoles/ml GF). Urinary cyclic AMP (cAMP/m1 GF)
was in HDP 76.9 7.4 and in LPD 48.2 1.4 pmoles/ml GF, suggesting
rapid inhibition of PTH after the first LPD meal. In thyroparathyroidec-
tomized rats Na-PiT in BBMV is similarly stimulated 2 hr after LPD. In
conclusion, the Na-PiT system in BBMV responded rapidly to 1.PD. As
for long-term adaptation, the early response of this system was PTH-
independent. Its relation with the associated acute hypophosphatemia,
and its importance in the rapid fall in UPi/mI GF remain to be
elucidated.
Duodenal and jejunal calcium (Ca) and phosphorus (Pi) transport in
the rat: Effects of phosphorus depletion and 1.25 (OH)2D3. H. Jun ghluth
and U. Binsoo'anger. Nephrologische Station, Deparrement Innere
Medizin, Universität Zorich, Zurich, Switzerland. To study the effects
of phosphorus depletion (LPD) and action of 1,25-dihydroxy vitamin D3
(1,25(OH)2D3) duodenal and jejunal Ca and P1 transport were measured
in vitro under short-circuited conditions in a modified Ussing appara-
tus. Net flux (Jnet) was calculated on paired tissue samples from the
same animals as met = Jms (niucosal-to-serosal flux) - Jsm (serosal-to-
mucosal flux).
ims
Diet N
Calcium Phosphorus
ism Jncl ims mm met
nn,olcu cm hr
Duodenum
Norrnidphosphorusdicl.NI'D 9 87a21 12± 2 76±21 14± 21 + 3 —7W
Lots phosphorus diet. LII) 9 169 46 18 a 1 III 41 44 17 36 Ii 8 14
LPD'-EHDI' 9 74±18 29±11 49±17 3± 9 46±22 —33±22
LPL) * El-ID!' I ,251011),D, 8 219 a 16 30 a 4 189 18 hi ' 18 97 * 13 4 a 26
Jejunum
Normal phosphorus diet. NPD RI 19 6 26 7 —7 6 51 IS 43 a 14 9 a IS
Lots phosphorus diet. PD 10 38 12 24 7 14 14 68 20 35 13 33 a 19
LPF) + El-liSp 8 4 ' 5 33 II —19 9 45 39 43 a 21 3 a 19
LPD+-EHDP+I2510H1D 8 38±15 Sbr 9 2±12 67±26 50±12 9±30
in conclusion, after a normal phosphorus diet Ca was absorped in the
duodenum but not in the jejunum. Increasing synthesis of 1,25(OH)±D3
resulting from phosphorus depletion (LPD) stimulated both Ca and Pi
absorption in the duodenum as well as in the jejunum. Similar results
were obtained by the use of EHDP (disodium ethanc-I-hydroxy-1,1
diphosphonate), which is known to decrease synthesis of I ,25(OH)2D3,
and by injection of l,25(OH)2D3. Our results underline the most
important role of l,25(OH)2D3 in regulating intestinal Ca and Pi
absorption.
Inhibition of the sodium transport by a natriuretic factor in rat's
isolated colon mucosa. B. Martin and H. Favre. Division of Nephrology,
Department of Medicine, Hôpital Cantonal Universitaire de Genêve,
Geneva, Switzerland. Natriuretic factor (NF) was isolated as previously
reported from the urine of salt-loaded subjects by G 25 Sephadex
chromatography. The natriuretic fraction, proven by rat assay, was
applied to rat's colon mucosa mounted in a chamber (Ussing). SCC and
PD were recorded at 5-mm intervals. Colon mucosa were stripped off
from the ascending colon of rats fed Na. 0.5 (group 1), 3 (group 2), and 6
(group 3) mmoles/day. Basal values for SCC and PD depended on the
salt intake; the lowest values were observed in group I and the highest
ones in group 3. NF inhibited SCC and PD only when added to the
serosal side of the membrane (maximum inhibition 60% after 90 mm;
the differences in slopes between control and experimental animals was
P < 0.001). In contrast with animals from groups 1 and 2 where a lag
period was observed, NF inhibited immediately the SCC and PD in
animals from group 3. Inhibition was characterized by a double slope
system in group 3 opposing to a one-slope system in groups I and 2. The
time-course of this sodium transport inhibition was similar to the one
observed when ouabain was added to the bath in place of the NF. In
conclusions. (1) NF acts on organs responsible for the sodium transport
other than kidneys. (2) NF mimics the effect of ouabain. (3) NF may act
both through the sodium NA-K AI'Pase-dependent system and through
the sodium chloride-dependent cotransport as suggested by the results
obtained in group 3.
Different immunosuppressive activity of equimolar prednisone, pred-
nisolone sodium phosphate and prednisolone sodium phthalate. B. M.
Frey, C. Walker, F. J. Frey, and A. L. de Weck. Medizinische
Poliklinik, Depart,nents of Clinical Pharmacology and Clinical immu-
nology, University of Bern, Bern, Switzerland. Renal allograft rejec-
tions are often treated with high doses of steroids such as oral
prednisone (P), intravenous prednisolone sodium phosphate (Pop), or
intravenous prednisolone sodium phthalate (Poph). We have evidence
that the systemic availability of prednisolone (Pa) differs between these
three steroids. Thus, the purpose of the present study was to determine
whether these differences in kinetics are of biological importance. Five
healthy volunteers were given oral P. intravenous Pop, or intravenous
Poph. The three steroids were given randomly on three occasions in
equimolar doses corresponding to 0.5 mg/kg of Po. After blood samples
were collected over a 24-hr period, unbound Po was determined by
HPLC and equilibrium dialysis. The immunosuppressive activity of the
volunteers' plasma was determined as the inhibition of the mixed
lymphocyte reaction. The area under the plasma concentration versus
time curve (AUC) of unbound Po and the area under the inhibition
versus time curve (AUIC) of the mixed lymphocyte reaction, a measure
of the immunosuppressive capacity over time, were determined. After
intravenous Poph or oral P the mean AUCs of unbound Po were 45 and
61% of that obtained after the administration of intravenous Pop, and
the corresponding AUICs were 75 and 68%, indicating lower systemic
availability of Po and less immunosuppressive effect in plasma after oral
P and intravenous Poph than after intravenous Pop. To establish
whether these results are paralleled by dynamic measurements in viva,
T cell subset distributions were analyzed and the ability to produce IL-2
was determined using peripheral lymphocytes obtained at various time
points after the dosing of the three steroids. After steroid doses
corresponding to I mg/kg of Po were given, a transient inhibition greater
than 80% of the IL-2 production was observed with all three glucocorti-
coids also given, while the maximal inhibition of the IL-2 production
was 60, 30, and 22% after a low dose (0.1 mg/kg) of Pop, P, or Poph.
After the low dose only minimal changes in the percentage of the
OKT4+ and OKT8+ cells were detectable, while after the high dose of
all three steroids the ratio of the OKT4+ to the OKT8+ cells dropped
with the decline being more pronounced after Pop than after Poph or P.
This study demonstrates that the dose and the systemic availability of
Po from a prodrug are determinants of the biological effect, a fact that
should be considered for therapeutic decisions.
Effect of pyridoxine on primary hyperoxyluria - type 1 in a child. P.
Alinei, P. Jaeger, and f-P. Guignard. Service de Pediatric ci Departe-
ment de MCdecine, CHUV, Lausanne, Switzerland. Primary hyperox-
aluria is an inherited metabolic disorder transmitted in an autosomal
recessive mode. Type I is characterized by a deficiency of the cytoplas-
mic enzyme alpha-ketoglutarate glyoxylate carboligase. The clinical
manifestations are those of nephrocalcinosis, stone formation, and
progressive renal insufficiency. A female infant was admitted to our
hospital at the age of 3 months for investigation of paleness. On
admission body weight was 4.450 g (P 10 to 25) and height 59 cm (P 50).
The infant presented with severe anemia (hemoglobin, 70 g/liter),
metabolic acidosis (P-HCO1, 11 mmoles/liter; base excess —14.3
mmoles/liter, and pronounced chronic renal failure (P-creatinine, 170
smoles/liter; creatinine clearance, 13 ml/min/l.73 m2). An IVP showed
slow excretion of the contrast agent and normal-sized kidneys; a
voiding cystogram showed a normal urinary tract. Renal biopsy demon-
strated tubular lesions with numerous birefringent fan-shaped crystals;
the interstitium was surrounded by an inflammatory infiltrate including
giant cells and slight fibrosis. The urinary oxalate/creatinine concentra-
tion ratio reached 0.74 (mmoles/mmole) (N < 0.086). The diagnosis of
primary hyperoxaluria-typc 1 was confirmed by the finding of a high
excretion of glycolic acid, glyoxylic acid, and oxalic acid. The infant
was started on pyridoxine, 300 mg daily and NaHCO3, 10 mmoles/day.
During the 19 months of follow-up, body weight and height increased to
9760 g and 80 cm, respectively. A progressive fall in the urinary
oxalate/creatinine ratio to 0.219 and a marked improvement in renal
function was noted; the creatinine clearance increased to 74 ml/min/l.73
m2, and the plasma creatinine level decreased to 55 zmoles/liter. This
patient report underlines the efficacy of high doses of pyridoxine in
reversing the oxalate-induced impairment in renal function present in
primary hyperoxaluria type I.
Renal allotransplantation in highly sensitized recipients across a posi-
tive crossmatch for donor B-lymphocytes. D. Frei and M. Jeannet.
Nationales Referenzlabor far Swisstran.splant, Transplantationsim-
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munologie Universitätsspital, Genéve Geneva, Switzerland. A posi-
tive serological crossmatch against donor lymphocytes generally results
in hyperacute rejection of the allograft. However, renal aliotransplanta-
tion across a B-cell positive, but a T-cell negative crossmatch was
shown not to result in hyperacute rejection episodes, but it is not clear
whether this is also true in hyperimmunized patients. The purpose of
the present study was to determine the influence of high sensitization
and positive B-cell crossmatch due to alloantibodies on the survival of
renal allografts. Since January 1981, B-cell crossmatch tests on fresh
donor B and T lymphocytes separated from spleen have been done in 38
highly presensitized patients in the frame of Swiss transplantation (long
incubation assays: 1 hr incubation with serum and lymphocytes, 2 hr
with complement). High presensitization was defined by the presence
of anti-HLA antibodies active on more than 50% of the panel lympho-
cytes. Thirteen patients had a positive and 20 had a negative B-cell
crossmatch. In the remaining five patients, the test was a technical
failure. The graft outcome in these two groups is the following: Nine out
of 13 patients (69%) with a positive versus 12 out of 20 patients (60%)
with a negative B-cell crossmatch still have a functioning graft. It must
be pointed out that among the patients with a positive B-cell cross-
match, seven also had a positive T-cell crossmatch (long incubation
assay) and three B- and T-lymphocytes autoantibodies. Thus, graft
survival in highly sensitized patients with a positive B-cell crossmatch
is as good, if not better, as that in patients with a negative B-cell
crossmatch. These preliminary results suggest that renal allografts may
be performed with a reasonable assurance of success in the presence of
a positive B-cell crossmatch due to alloantibodies, even in highly
sensitized patients.
Ultrastructure of the rat proximal tubule after acute administration of
the chelate cadmium-pentetic acid (DTPA). R. Polikar and M. Cam-
piche. Institut de Pathologie de lUniversité, Lausanne, Switzerland.
Sixteen anesthetized male Wistar rats (220 to 290 g) received constant
intravenous infusions (12 ml/hr) during 70 mi Thirty minutes to 3 hr
after the end of the infusion, the kidneys were fixed by aortic perfusion
of 2% glutaraldehyde in cacodylate buffer at a pressure of 100 mm Hg.
Suitably oriented fragments at all levels were postflxed in 0S04 and
embedded in Epon 812. Eight groups of two animals were investigated.
Kidneys fixed 3 hr after infusion of saline containing 0.15 m cadmium
acetate showed only a mild increase of the number and size of clear
lysosomes in the S2 segments, when compared with control rats having
received saline alone. In the other groups, DTPA was added to the
infusion solution in increasing concentrations. Kidneys from animals
infused with 5.4 mri DTPA alone or with cadmium (molar ratio
DTPA:Cd = 36) were similar to those of control rats. After infusion
with IS m DTPA alone, the number and size of subapical vacuoles
was mildly increased in S1 and S2; some S2 segments contained very
few of the usual dense lysosomes but numerous clear lysosomes; some
S segments contained very many large lysosomes with crystalline
dense structures. When cadmium was added to 15 mi DTPA
(DTPA:Cd = 100), the changes in S were more noticeable and the
crystalline structures in S2 were rarely observed. After infusion with 54
mM DTPA, the brush border of all three segments was damaged to a
varying degree; the size and number of vacuoles in S and S2 were
markedly increased: S3 segments showed numerous subapical vacuoles
and numerous areas of closely packed vesicles of smooth-surfaced
endoplasmic reticulum (SER). When cadmium was added (DTPA:Cd =
360), the vacuoles were confluent and extended to the whole cytoplasm
of S1 and, to a lesser degree, of S2 segments; the areas of SER were
distinctly more apparent in the S3 segments. These findings indicate
mainly an increase in endocytosis; no morphological change related to
the known tubular secretion of the chelate CD-DTPA was observed.
The classification of idiopathic hypercalciuria is challenged by evalua-
tion of dietary habits and tubular function of stone-formers. P. Jaeger, L.
Portmann, A. F. Jacquet, E. Maeder, and P. Burckhardt. Department
of Medicine, University Hospital of Lausanne, Lausanne, Switzerland.
Until recently it has been accepted that idiopathic stone formers (1SF)
who remain hypercalciuric on a low calcium (Ca) diet have a renal leak
of calcium, that is, renal hypercalciuria. However, recent evidence
suggests that besides Ca, other dietary factors, for example, high
sodium (Na), protein and/or carbohydrate intake lead to hypercalciuria.
Therefore, the incidence of renal hypercalciuria defined as above has
probably been widely overestimated in the past. Out of 106 male 1SF, 35
were found hypercalciuric (UCaV >250 mg/24 hr) when studied after 5
days on a low Ca diet (mean daily Ca intake about 300 mg). On this diet,
a dependance of urinary calcium excretion on sodium intake was
observed in a control population made of 36 male normocalciuric ISFs.
UCaV was found significantly (P < 0.05) correlated with UNaV (y =
0.27 x + 114, N = 36, r = 0.34). Calculation of the confidence limits
around the regression line UCaV versus UNaV revealed that only nine
out of the 35 patients with hypercalciuria on a low Ca diet actually had
calcium excretion out of proportion to sodium excretion as it would be
expected for renal hypercalciuria. However, three of these nine patients
appeared to have a high daily protein intake, as reflected by hyperurico-
suria (>850 mg/24 hr), a condition leading to high calcium excretion
relative to sodium excretion. Therefore, only six patients out of 106 1SF
might have been regarded as having probably a renal leak of Ca.
However, looking retrospectively at the IVP's of these six patients it
appeared that one of them had medullary sponge kidneys. To further
evaluate the renal tubular function of patients with nephrolithiasis, the
following determinations have also been made in the 2-hr fasting
morning urine in 30 1SF: fractional excretion of glucose, insulin, and
bicarbonate (the latter before and after an alkali load), excretion of
lysozyme and y-glutamyl transferase (GT). Preliminary data showed a
low (7 to 10%) incidence of renal leak of glucose, insulin, QT, and
lysozyme, and a high (65%) incidence of bicarbonate leak, but the
incidence of these various leaks was similar in 16 normocalciuric 1SF
and in 14 1SF with hypercalciuria on low Ca diet. In conclusion, renal
hypercalciuria is very rare, and in a large percentage of 1SF, hypercal-
ciuria has rather a dietary origin. Some 1SF do have signs of renal
tubular dysfunction, but the incidence of this disorder does not seem to
be related to the subgroup of idiopathic stone disease to which the
patient belongs.
Renal excretion of the chelate cadmium-pentetic acid in rats. A.
Borgeat and J. Diezi. Institut de Pharmacologie de l'Université,
Lausanne, Switzerland. The urinary excretion of the chelate cadmium-
pentetic acid (Cd-DTPA, made by adding Cd acetate to Ca-DTPA) was
investigated, using standard clearance techniques, in anesthetized male
Wistar rats (250 to 300 g). Three 30-mm clearance periods were carried
out, one before (control) and two during (experimental) constant
intravenous infusion (12 ml/hr) of saline containing the Cd-DTPA
chelate (0.15 mti Cd; molar ratio DTPA/Cd: 36). Cd in arterial plasma
and urine was measured by flameless atomic absorption spectroscopy.
The following observations were made: (I) In all rats (N = 6), Cd-DTPA
clearance (measured as Cd) was higher than GFR in both experimental
periods; FECd averaged 205 14% in the second experimental period.(2) FECd was reduced to 112 3% when DTPA concentration in the
infusion was increased by ten times (Cd/DTPA molar ratio 360) but was
unaffected by probenecid. (3) The decrease of FECd during infusion of
high concentration of DTPA was reversible when DTPA concentration
in the infusion was again reduced during an additional clearance period.
(4) Infusion of Cd-DTPA did not affect GFR. Thus, it appears that the
chelate Cd-DTPA is secreted by renal tubules and that this transport
occurs through a mechanism different from that of organic anions in
proximal tubules.
Facilitated transport mechanisms involved in proximal salicylate reab-
sorption. L. Schild and F. Roch-Ramel. Institut de Pharmacologie,
Lausanne, Switzerland. The reabsorption of '4C-salicylate (Sal) was
measured in isolated rabbit S2 segments. Data were expressed in
fmoles min1 mm' of segment length (mean SE, N = number of
segments). The segments were perfused with a solution at pH 7.4
(phosphate buffer 2 ms, NaCI ISO mrt, CaCI2 1 msi, MgSO4 1.2 mM).
When the bath was buffered to pH 7.4 with 20 mM HEPES (no
HC03/CO2 buffer), no significant reabsorption was observed (43 34,
N = 5). These observations demonstrate that the passive non-ionic
back diffusion of salicylate was negligible in the S2 segment. Lowering
the perfusate pH to 6.6 did not increase reabsorption (52 27, N = 5).
When the bath was buffered to pH 7.4 with CO2/HC03 (Pco2 = 40mm
Hg), reabsorption was statistically significant (128 17, N = 12).
Reabsorption was further increased when Pco2 was 120mm Hg (433
34, N = 7). In these experimental conditions, the bath pH was 7. This
further stimulation of salicylate reabsorption by Pco2 was secondary to
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the lowering of bath pH because, if bath Pco2 was kept low (15mm Hg)
and pH lowered to 7 with HEPES, reabsorption was identical to that
observed with high Pco2 (426 49, N = 12). In these conditions, the
addition of 20 msi HEPES or 15 mEq HCO3 to the perfusate reduced
the reabsorption to 119 23 (N = 6) and 152 87 (N = 10),
respectively. The acidification of the bath stimulated the secretion of
protons from cell to lumen and increased the cell to lumen 0H
gradient. Buffering the perfusate decreased this gradient. We suggest
that our data show that salicylate anions might exchange with 0H at
the luminal membrane. Replacing NaCI of perfusate with Na gluconate
also increased salicylate reabsorption by 80% (N = 4). Such a maneuver
created a cell to lumen Cl gradient favoring the exchange of luminal
salicylate with cell Cl. Thus, a salicylate exchange with affinity for
0H and C1 appears to exist at the luminal membrane.
